|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,454.00 GBX | +0.45% |
|
+1.55% | +52.01% |
| 09/07 | FTSE 100 held back by AstraZeneca trial setback | AN |
| 09/07 | UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains | RE |
| Market Cap | 467.44Cr 627.3Cr 548.7Cr 506.11Cr 886.96Cr 60TCr 901.87Cr 6.05TCr 2.37TCr 29TCr 2.36TCr 2.3TCr 1,01300Cr | P/E 2026 * |
21.5x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 420.47Cr 564.26Cr 493.56Cr 455.25Cr 797.82Cr 54TCr 811.24Cr 5.44TCr 2.14TCr 27TCr 2.12TCr 2.07TCr 91TCr | EV / Sales 2026 * |
0.37x | EV / Sales 2027 * | 0.35x |
| Free-Float |
36.71% | Yield 2026 * |
1.93% | Yield 2027 * | 2.05% |
| 1 day | +0.45% | ||
| 1 week | +1.55% | ||
| Current month | +4.21% | ||
| 1 month | +7.85% | ||
| 3 months | +44.33% | ||
| 6 months | +40.59% | ||
| Current year | +52.01% |
| 1 week | 4,092 | 4,702 | |
| 1 month | 4,090 | 4,702 | |
| Current year | 2,794 | 4,702 | |
| 1 year | 2,092 | 4,702 | |
| 3 years | 1,994.3 | 4,702 | |
| 5 years | 1,780 | 4,702 | |
| 10 years | 666.45 | 4,702 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Norris
CEO | Chief Executive Officer | 65 | 01/12/1994 |
Keith Mortimer
DFI | Director of Finance/CFO | 53 | 01/09/2025 |
John Gibbs
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Norris
BRD | Director/Board Member | 65 | 30/03/1998 |
Peter Ogden
CHM | Chairman | 79 | 03/10/1995 |
Philip Hulme
CHM | Chairman | 78 | 03/10/1995 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/05 | Fiscal year | 203 | 0.0002% | |||
| 28/04 | Sell | Chief Executive Officer | 49,560 | 0.0466% | ||
| 28/04 | Fiscal year | Chief Executive Officer | 49,560 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.45% | +1.55% | +97.96% | +106.39% | 627.3Cr | ||
| -2.62% | -0.68% | +0.05% | +116.37% | 27TCr | ||
| -2.26% | +0.50% | +21.93% | +54.11% | 9.06TCr | ||
| -2.75% | -1.54% | -53.10% | -56.16% | 8.28TCr | ||
| +0.95% | -1.17% | -38.82% | -36.77% | 7.85TCr | ||
| +1.77% | +3.56% | -39.45% | -2.30% | 5.72TCr | ||
| +1.64% | +1.99% | -33.90% | -19.65% | 4.53TCr | ||
| -1.33% | +0.63% | +2.73% | +85.84% | 3.59TCr | ||
| -1.21% | +3.96% | +12.08% | +216.37% | 3.56TCr | ||
| +1.19% | +2.20% | -30.03% | +3.52% | 3.3TCr | ||
| Average | +0.04% | +1.10% | -6.06% | +46.77% | 7.35TCr | |
| Weighted average by Cap. | -0.77% | +0.25% | -12.35% | +53.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.13TCr 1.52TCr 1.33TCr 1.22TCr 2.14TCr 1,44600Cr 2.18TCr 15TCr 5.74TCr 71TCr 5.69TCr 5.57TCr 2,44900Cr | 1.17TCr 1.57TCr 1.38TCr 1.27TCr 2.22TCr 1,50000Cr 2.26TCr 15TCr 5.95TCr 74TCr 5.91TCr 5.78TCr 2,54100Cr |
| Net income | 22Cr 29Cr 26Cr 24Cr 41Cr 2.78TCr 42Cr 281.3Cr 110.47Cr 1.37TCr 109.56Cr 107.18Cr 4.71TCr | 24Cr 32Cr 28Cr 26Cr 45Cr 3.02TCr 46Cr 305.49Cr 119.97Cr 1.49TCr 118.99Cr 116.4Cr 5.12TCr |
| Net Debt | -47Cr -63Cr -55Cr -51Cr -89Cr -6.01TCr -91Cr -607.71Cr -238.65Cr -2.96TCr -236.7Cr -231.55Cr -10TCr | -56Cr -76Cr -66Cr -61Cr -106.91Cr -7.21TCr -108.7Cr -728.87Cr -286.23Cr -3.55TCr -283.89Cr -277.71Cr -12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | GBX 4,454.00 | +0.45% | 5,04,067 |
| 09/26/09 | GBX 4,434.00 | +7.21% | 9,56,244 |
| 08/26/08 | GBX 4,136.00 | -2.54% | 2,41,522 |
| 07/26/07 | GBX 4,244.00 | -3.59% | 2,36,556 |
| 06/26/06 | GBX 4,402.00 | +0.36% | 2,10,986 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CCC Stock
Select your edition
All financial news and data tailored to specific country editions
















